Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis.

Cancer Treatment and Research Communications
Tengfei ChenJun Zhao

Abstract

Exosomes in the tumor microenvironment (TME) facilitate tumor progression by enabling inter-cellular communication. Tumor cell-derived exosomes can polarize tumor-associated macrophages (TAMs) to an immunosuppressive M2 phenotype. The aim of this study was to determine the role of exosomal circFARSA in non-small cell lung cancer (NSCLC) and elucidate the underlying mechanisms. In situ circFARSA expression in NSCLC tissues was analyzed using qRT-PCR. The in vitro migration of NSCLC cells was evaluated using a transwell assay or through indirect co-culture with M2 macrophages, as appropriate. Immunoprecipitation (IP), western blotting, RNA binding protein immunoprecipitation (RIP), and RNA pull down assays were conducted for mechanistic studies. CircFARSA was significantly upregulated in NSCLC tissues, and the ectopic overexpression of circFARSA enhanced NSCLC cell metastasis. Furthermore, NSCLC cell-derived exosomal circFARSA polarized the macrophages to a M2 phenotype. The NSCLC cells co-cultured with macrophages transfected with circFARSA or pre-treated with exosomal circFARSA showed enhanced EMT and metastasis. Mechanistically, exosomal circFARSA induced M2 polarization via PTEN ubiquitination and degradation, which further a...Continue Reading

References

Apr 15, 2015·Nucleic Acids Research·Anna-Lena SteckelbergNiels H Gehring
Sep 25, 2015·Scientific Reports·Ang YuanPan-Chyr Yang
Nov 20, 2015·American Journal of Respiratory and Critical Care Medicine·Emma M ConwayKevin L Bennewith
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Mar 6, 2016·Journal of Medical Genetics·Yonghua ChenXubao Liu
Apr 2, 2016·The Journal of Clinical Investigation·Raghu Kalluri
Aug 31, 2016·Lancet·Fred R HirschLuis Paz-Ares
Jan 25, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eleni VergadiChristos Tsatsanis
Mar 28, 2017·Pathology, Research and Practice·Jun-Tao YaoKe-Jun Nan
May 20, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Satoru YanagisawaPeter J Barnes
Jan 3, 2018·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ya-Ling HsuPo-Lin Kuo
Feb 13, 2018·Oncotarget·Ya-Wen SunWen-Juan Liu
Jun 29, 2018·Cell Death & Disease·Géraldine GenardCarine Michiels
Oct 3, 2018·Journal of Cellular Biochemistry·Masoud NajafiKeywan Mortezaee
Jan 19, 2019·Cancer Management and Research·Huifei ZhengJun Zhao
Jan 22, 2019·International Journal of Biological Sciences·Tao Huang, Chu-Xia Deng
Feb 9, 2019·Cell·Josh N VoArul M Chinnaiyan
Jun 4, 2019·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuting SangQifeng Yang
Apr 17, 2020·Signal Transduction and Targeted Therapy·Chenzhi ZhangXiao Xu
May 24, 2020·Annals of the New York Academy of Sciences·Martha Lopez-YrigoyenJeffrey W Pollard
May 28, 2020·Cells·Alexandra PritchardJessy S Deshane
Jul 28, 2020·Cancers·Anna Maria MalfitanoGiuseppe Portella

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.